Singapore The executive director of the Singaporean-German Chamber of Industry and Commerce explains the evolution of the business relationship between Singapore and Germany, cultural similarities and challenges, and showcases the chamber as a platform to further enhance bilateral economic relations between the two nations. Could you please introduce to our international…
Slovakia Slovakia has been Europe’s fastest growing economy over the last ten years and the government has identified areas within life sciences as strategic centers for investment in the country. Slovakia has a lot to offer biopharma investors according to Robert Simoncic, head of the Slovak investment and trade development agency…
Philippines Peter Kompalla, executive director of the German-Philippine Chamber of Commerce and Industry, discusses the chamber’s activities in the country working to promote German-Filipino trade, their extensive and growing advocacy efforts on behalf of their members, as well how good business values help to bond German companies of all sizes operating in the…
Pharma Francisco González, CEO of ProMéxico, the Mexican investment agency, describes the strengths of Mexico’s research and industrial base, untapped business opportunities in the pharmaceutical and healthcare sectors, and new export horizons in Africa and Asia. Mexico currently displays a very interesting business context: the economy is back to robust growth…
Pharma Philippe Richert, President of the newly created region Grand Est (Regions Alsace, Champagne-Ardenne and Lorraine) shares the significance of life sciences to his local economy, the industrial heritage which have made the region a leading exporter of pharmaceuticals, as well as the world-class innovation taking place there. Finally, he discusses…
Pharma Martin Naville, CEO of the Swiss-American Chamber of Commerce, discusses Swiss exports to the US, global competitiveness and innovation rankings, and why the Swiss-US relationship will only continue to grow stronger in the coming years. In 2015, the US was the most important destination for Swiss direct investment abroad, amounting…
Pharma The Director of the State Institute for Drug Control in the Czech Republic highlights the Czech pharmaceutical industry as emancipated and points out their tremendous contribution to employment, export balance, the economy at large and to the patients. You assumed the position as interim director of the State Institute for…
Pharma Hungary’s Minister of Foreign Affairs and Trade Péter Szijjártó highlights the significant role that foreign direct investments have played in developing the country’s healthcare and life science sector, while detailing the nation’s ambitions of not only pivoting into Europe’s hub for production, but also innovation. With over a century-long tradition,…
Pharma Agnès Ducrot and Miklos Maróthy of CCI France Hongrie discuss their advocacy efforts in Hungary and the history of French investment in the country. They also discuss the challenges and opportunities facing companies currently operating in the country. Can you give our readers an overview of the Chamber’s activities here in…
Pharma As CEO of the newly formed government agency Business France, Muriel Pénicaud is passionate about championing French innovation and creativity, particularly in life sciences. She tells us about her organization’s key objectives, ongoing efforts to change perceptions about France’s business environment, and her ‘bilingualism’ in the worlds of business and…
Italy Sofia Astrid Pennacchi, Secretary General of the British Chamber of Commerce for Italy, discusses the various services the Chamber offers its members, the positive effects the Expo has had on Italy’s international image and her view on the trade relationship between Britain and Italy. Ms. Pennacchi, having joined the British…
Pharma Empty markets, where strong and growing demand exists but local supply does not, offer the most potential to prospective investors in Egypt, according to Delta Pharma Bio general manager Mohamed Aldeeb. Aldeeb goes on to explain that such markets include oncology, biosimilars, and baby formula. What makes Egypt ‘the land of…
See our Cookie Privacy Policy Here